Saskatchewan

Image: 
Thu
16
Jul

Saskatoon company isolates coronavirus antigen in plant cells

A Saskatoon life sciences company known for its work with medical cannabis says it has successfully isolated the antigen for SARS-CoV-2 in plant cells.

Zyus Life Sciences Inc. CEO Brent Zettl says it’s an important first step that shows plants can effectively “photocopy” proteins that could be ingredients in a COVID-19 vaccine.

Thu
02
Jul

We ranked Canada's cannabis-friendly provinces from worst to best

Canadians are clearly in love with cannabis, but not all provinces were created equal when it comes to permitting pot. While the historic Cannabis Act applies to all provinces, the rules around distribution and consumption fall to the provinces — and municipalities have some say on it, too.

That’s why for Canada Day, The GrowthOp takes a look at the growing industry from coast-to-coast — crunching the data on price, consumption habits, number of stores, public consumption options and the ability to grow at home — to find out which provinces are rolling out the red carpet for weed and which are still warming up to the country’s second favourite leaf.

Here are our findings.

Thu
25
Jun

Pure Sunfarms starts shipping to Saskatchewan and Manitoba

Pure Sunfarms, the joint venture between veteran vegetable grower Village Farms International Inc. (TSX and NASDAQ: VFF) and medical cannabis company Emerald Health Therapeutics Inc. (TSX-V: EMH), began shipping its products to Saskatchewan Wednesday.

Thu
18
Jun

City of Saskatoon committee recommends significant reduction in cannabis retailer license fees

The City of Saskatoon’s Planning, Development and Community Services Committee has unanimously recommended that cannabis retailer license fees be reduced from the current $20,000 to $4,500 when the SLGA begins accepting new applications for stores in September.

Subsequent business license renewals are expected to remain at $85 annually. To date, $120,000 in revenue from business licensing fees has been received.

Tue
12
May

Saskatoon medical cannabis firm working with researchers on potentially 'plant-based' COVID-19 vaccine

A local firm specializing in medical cannabis science is lending its expertise to the University of Saskatchewan-based VIDO-InterVac research lab's quest for a COVID-19 vaccine.

The lab, which received 23 million dollars in federal funding in March to aid its COVID-19-related research, recently moved into animal trials as part of its research.

Mon
04
May

Canopy Growth sees up to $800M charge on global restructuring

Canopy Growth Corp. announced sweeping changes Thursday across its global operations aimed at cutting costs that will result in a charge of up to $800 million and a headcount reduction of 85 full-time positions.

Canopy said it will exit Africa, cease cultivation in Colombia, shut down its Saskatchewan production facility, and halt hemp cultivation in New York due to an oversupply of the product from last year's growing season. 

"When I arrived at Canopy Growth in January, I committed to conducting a strategic review in order to lower our cost structure and reduce our cash burn," said David Klein, Canopy’s chief executive officer, in a statement. 

Tue
31
Mar
Thu
26
Mar

Where to buy weed during the COVID-19 pandemic

Approximately 4,000 times these past two weeks, I’ve thanked my lucky stars cannabis was legalized before the COVID-19 pandemic swept the globe and sent us all cowering in our bong dens.

Tue
17
Mar

Canopy Growth closing legal pot shops amid virus outbreak

Canopy Growth Corp. is temporarily shutting down its corporate-owned cannabis stores across the country Tuesday due to the COVID-19 outbreak, the company said in a statement. 

Canopy, which owns 23 legal cannabis stores in Manitoba, Saskatchewan and Newfoundland and Labrador, will close its stores for an undetermined period of time at 5 p.m. local.  It is also closing its visitors centre located at its headquarters in Smiths Falls, Ont. 

“We have a responsibility to our employees, their families, and our communities to do our part to ‘flatten the curve’ by limiting social interactions. For us, that means shifting our focus from retail to e-commerce," said David Klein, chief executive officer of Canopy Growth, in a statement. 

Wed
12
Feb

Sask. doctor fined $15,000 for improperly prescribing pot

A Humboldt doctor has been ordered to pay nearly $24,000 after prescribing cannabis to nearly 1,000 patients over six weeks in 2017 while working in Saskatoon.

Dr. Mishack Zwane admitted to charges of unprofessional conduct laid by the College of Physicians and Surgeons of Saskatchewan. The college alleged Zwane did not comply with college bylaws around the prescription of cannabis nor did he appropriately bill the province’s medical plan for his assessments of patients.

Pages

Subscribe to RSS - Saskatchewan